查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1925094

全球神经多样性评估和筛检平台市场预测至2032年：按组件、年龄层、部署类型、应用、最终用户和地区划分

Neurodiversity Assessment & Screening Platforms Market Forecasts to 2032 - Global Analysis By Component (Software Platforms and Services), Age Group, Deployment Mode, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的一项研究，全球神经多样性评估和筛检平台市场预计到 2025 年将价值 3.5 亿美元，预计到 2032 年将达到 7.8836 亿美元。

预计在预测期内，神经多样性评估和筛检平台将以12.3%的复合年增长率成长。这些平台是基于技术的解决方案，有助于检测和了解各种神经系统疾病，例如泛自闭症障碍、注意力不足过动症（ADHD）和学习障碍。它们结合了数位调查问卷、数据分析和智慧演算法，提供准确的筛检和个人化回馈。这些平台透过支援线上评估和为学校、职场和医疗保健机构提供一致的报告，提高了评估的可近性。它们支持早期发现和持续监测，从而能够制定更有效的干预策略和个人化支持计划。总而言之，这些平台在创造支持性环境方面发挥着至关重要的作用，这些环境能够认可和尊重学术、临床和专业环境中的认知多样性，减少歧视，促进包容。

根据美国国家医学图书馆 2021 年的研究，自闭症成年人的失业率约为 40%，明显高于一般人。

人们对神经多样性的认识不断提高

机构和社会对神经多样性的理解不断加深，是推动市场成长的主要动力。教育机构、医疗机构和雇主越来越将神经差异视为人类多样性的一部分，催生了对系统性筛检解决方案的需求。宣传宣传活动和支持性政策强调了早期发现和个人化治疗的重要性。随着社会偏见的减少，越来越多的个人和组织愿意采用结构化的数位化评估。这种文化转变推动了对能够评估认知差异、指导介入措施和支持包容性的便利平台的需求，最终促使神经多样性评估和筛检技术在多个领域得到更广泛的应用。

高昂的实施和维修成本

部署和维护神经多样性评估平台的高成本限制了市场成长。这些解决方案依赖先进技术，需要大量的初始投资和持续的资金支持。机构还必须为培训、升级、网路安全和平台整合分配预算。即使认识到长期价值，小规模的机构也往往难以证明这些投资的合理性。因此，成本敏感性成为一大障碍，减缓了采用率，并限制了数位神经多样性筛检解决方案的广泛应用，尤其是在价格敏感的市场中。

拓展至企业人力资源与人才管理领域

包容性招募实践的日益普及为市场带来了巨大的成长潜力。企业正在寻求可靠的工具来了解其神经多样性员工群体，并制定支持性的职场策略。神经多样性筛检平台可以整合到人力资源流程中，以确保公平招募、个人化入职和员工发展。透过将个人优势与职位描述相匹配，企业可以提高员工敬业度和绩效。随着企业越来越重视多元化和包容性，这些平台有机会从医疗保健和教育产业扩展到企业级人才管理解决方案领域。

竞争加剧和市场分散化

日益激烈的竞争压力对市场稳定构成重大威胁。提供类似筛检功能的解决方案供应商数量激增，加剧了竞争并导致需求分散。激进的定价策略和缺乏差异化可能会削弱获利潜力。现有技术公司凭藉其规模和品牌影响力进入市场，进一步加剧了竞争。日益激烈的竞争可能意味着小规模或专注于特定领域的平台提供者难以维持市场份额，从而增加了整合或退出市场的可能性，限制了其长期成长机会。

新冠疫情的影响：

新冠疫情显着影响了神经多样性评估和筛检平台市场，推动了虚拟评估技术的快速普及。人际接触限制减少了面对面评估的机会，迫使学校、诊所和机构使用线上筛检工具。远端医疗和远端教育的扩展促进了数位平台的采用。同时，网路存取方面的差异以及对资料安全的担忧也日益凸显。这些因素正在影响创新重点，并推动开发更易于存取、更安全、更灵活的神经多样性筛检解决方案，以适应后疫情时代的需求。

预计在预测期内，软体平台细分市场将占据最大的市场份额。

预计在预测期内，软体平台细分市场将占据最大的市场份额，因为它们构成了神经多样性筛检和评估的核心基础设施。这些平台结合了评估工具、智慧分析和使用者友善的介面，能够在多个领域实现高效且可重复的筛检。它们的柔软性支援线上交付、个人化评估以及与现有系统的无缝整合。机构青睐软体平台，因为它们简化了大规模部署，提高了一致性，并减少了对人工流程的依赖。这种功能多样性和扩充性使得软体平台成为神经多样性评估和筛检解决方案中应用最广泛的细分市场。

预计在预测期内，成人（18岁及以上）细分市场将达到最高的复合年增长率。

预计在预测期内，18岁及以上成年人群体将呈现最高的成长率。人们越来越意识到，诸如注意力不足过动症（ADHD）、自闭症和阅读障碍等问题会持续到成年期，这促使更多人接受评估。机构和大学也越来越多地利用数位化平台来识别支援需求并完善包容性策略。成年人更倾向于柔软性、私密且线上的筛检方式，以适应他们忙碌的生活方式。这种成年人评估的趋势，加上职场包容性倡议和日益增强的自我意识，正在加速成人评估的普及，并使成年人群体成为市场中成长最快的类别。

占比最大的地区：

预计在预测期内，北美将占据最大的市场份额，这得益于其高度发展的技术生态系统和对神经多样性的高度重视。该地区受益于医疗保健、教育和就业领域早期对数位化解决方案的整合。各组织正积极利用筛检平台来支持包容性、合规性和早期疗育倡议。熟练专业人员的充足供应、有利的法规环境以及远端评估工具的高普及率正在推动市场渗透。这些因素共同作用，使北美在整体市场份额方面占据主导地位。

预计年复合成长率最高的地区：

预计亚太地区在预测期内将实现最高的复合年增长率，这主要得益于公众意识的提高和数位基础设施的扩展。教育和医疗机构正越来越多地转向线上筛检解决方案，以高效满足不断增长的需求。政府支持计画、行动技术的普及以及对包容性教育日益重视，都在推动这些解决方案的采用。该地区庞大且多元化的人口对便利的评估工具的需求，促使数位神经多样性平台迅速普及，使亚太地区成为全球成长最快的市场。

免费客製化服务：

购买此报告的客户可以选择以下免费自订选项之一：

  • 公司概况
    • 对其他市场参与者（最多 3 家公司）进行全面分析
    • 主要参与者（最多3家公司）的SWOT分析
  • 区域细分
    • 根据客户要求，提供主要国家的市场估算和预测以及复合年增长率（註：可行性需确认）。
  • 竞争标竿分析
    • 根据主要参与者的产品系列、地理覆盖范围和策略联盟进行基准分析

目录

第一章执行摘要

第二章 前言

  • 概括
  • 相关利益者
  • 调查范围
  • 调查方法
  • 研究材料

第三章 市场趋势分析

  • 司机
  • 抑制因素
  • 机会
  • 威胁
  • 应用分析
  • 终端用户分析
  • 新兴市场
  • 新冠疫情的感染疾病

第四章 波特五力分析

  • 供应商的议价能力
  • 买方的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球神经多样性评估和筛检平台市场（按组件划分）

  • 软体平台
  • 服务

6. 全球神经多样性评估与筛检平台市场（依年龄层划分）

  • 儿童（0-12岁）
  • 青少年（13-17岁）
  • 成年人（18岁以上）

7. 全球神经多样性评估与筛检平台市场（依实施类型划分）

  • 基于云端的
  • 本地部署

8. 全球神经多样性评估与筛检平台市场（按应用划分）

  • 阅读障碍筛检
  • ADHD筛检
  • 泛自闭症障碍（ASD）筛检
  • 共济失调筛检

9. 全球神经多样性评估和筛检平台市场（按最终用户划分）

  • 教育机构
  • 医疗保健提供者
  • 公司组织
  • 研究所
  • 政府机构

10. 全球神经多样性评估与筛检平台市场（按地区划分）

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 亚太其他地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美国家
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十一章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 併购
  • 新产品发布
  • 业务拓展
  • 其他关键策略

第十二章：企业概况

  • Lumosity
  • MoCA Cognition
  • HappyNeuron
  • Cognistat
  • BrainFx
  • Dystech
  • CogniFit
  • Cambridge Cognition
  • Creyos Health
  • CNS Vital Signs
  • Do-IT Profiler
  • GL Assessment
  • Qbtech
  • Gabify
  • Aignosis
Product Code: SMRC33488

According to Stratistics MRC, the Global Neurodiversity Assessment & Screening Platforms Market is accounted for $350.0 million in 2025 and is expected to reach $788.36 million by 2032 growing at a CAGR of 12.3% during the forecast period. Neurodiversity Assessment & Screening Platforms are technology-based solutions that help detect and understand diverse neurological conditions, such as autism spectrum disorders, ADHD, and learning differences. They combine digital questionnaires, data analysis, and intelligent algorithms to deliver accurate screenings and tailored feedback. These platforms make assessments more accessible by allowing online evaluations and consistent reporting for schools, workplaces, and healthcare providers. By supporting early identification and continuous monitoring, they enable better intervention strategies and personalized support plans. Overall, such platforms play a key role in promoting inclusion, reducing stigma, and creating supportive environments that recognize and value cognitive diversity in academic, clinical, and professional settings.

According to the National Library of Medicine (2021 study), the unemployment rate among autistic adults is around 40%, which is significantly higher than the general population.

Market Dynamics:

Driver:

Growing awareness of neurodiversity

Increasing understanding of neurodiversity among institutions and society is strongly fueling market growth. Educational bodies, healthcare providers, and employers now view neurological differences as part of human diversity, creating demand for systematic screening solutions. Awareness campaigns and supportive policies highlight the importance of early identification and tailored assistance. As stigma declines, more individuals and organizations are willing to adopt structured digital assessments. This cultural shift drives the need for accessible platforms that can evaluate cognitive differences, guide interventions, and support inclusion, ultimately expanding the use of neurodiversity assessment and screening technologies across multiple sectors.

Restraint:

High cost of implementation and maintenance

Elevated costs associated with deploying and maintaining neurodiversity assessment platforms restrict market growth. These solutions rely on sophisticated technologies that demand substantial upfront and ongoing financial resources. Organizations must also allocate budgets for training, upgrades, cybersecurity, and platform integration. Smaller institutions often struggle to justify such investments, even when the long-term value is recognized. As a result, cost sensitivity acts as a barrier, particularly in price-conscious markets, reducing adoption rates and limiting the widespread use of digital neurodiversity screening solutions.

Opportunity:

Expansion into corporate HR and talent management

Rising adoption of inclusive hiring practices presents significant growth potential for the market. Companies are looking for reliable tools to understand neurodiverse talent and design supportive workplace strategies. Neurodiversity screening platforms can be embedded into HR processes to enable fair recruitment, customized onboarding, and employee development. By aligning individual strengths with job roles, organizations can improve engagement and outcomes. As corporate focus on diversity and inclusion intensifies, these platforms gain opportunities to expand beyond healthcare and education into enterprise-level talent management solutions.

Threat:

Intensifying competition and market fragmentation

Rising competitive pressure represents a major threat to market stability. The increasing number of solution providers offering similar screening functionalities intensifies rivalry and fragments demand. Aggressive pricing strategies and limited differentiation can weaken revenue potential. Established technology firms entering the market further heighten competition due to their scale and brand strength. As competition grows, smaller or specialized platform providers may struggle to maintain market share, making consolidation or exit more likely and limiting long-term growth opportunities.

Covid-19 Impact:

COVID-19 strongly influenced the neurodiversity assessment and screening platforms market by driving rapid adoption of virtual assessment technologies. Restrictions on physical interactions reduced the availability of face-to-face evaluations, pushing schools, clinics, and organizations to use online screening tools. Growth in telehealth and remote education supported wider acceptance of digital platforms. At the same time, disparities in internet access and concerns over data security became more visible. These factors shaped innovation priorities, encouraging more accessible, secure, and flexible neurodiversity screening solutions for post-pandemic environments.

The software platforms segment is expected to be the largest during the forecast period

The software platforms segment is expected to account for the largest market share during the forecast period as they form the core infrastructure for neurodiversity screening and evaluation. By combining assessment tools, intelligent analysis, and user-friendly interfaces, these platforms enable efficient and repeatable screenings across multiple sectors. Their flexibility supports online delivery, personalized assessments, and seamless integration with existing systems. Organizations favor software platforms because they simplify large-scale implementation, improve consistency, and reduce dependence on manual processes. This functional versatility and scalability make software platforms the most widely adopted segment in neurodiversity assessment and screening solutions.

The adults (18+ years) segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the adults (18+ years) segment is predicted to witness the highest growth rate. Growing awareness that conditions such as ADHD, autism, and dyslexia persist into adulthood has encouraged more individuals to pursue evaluations. Organizations and universities increasingly use digital platforms to identify support needs and improve inclusion strategies. Adults prefer flexible, private, and online screening options that fit busy lifestyles. This shift toward adult-focused assessments, combined with workplace inclusion initiatives and rising self-advocacy, is accelerating adoption and positioning the adult segment as the highest-growth category in the market.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, supported by well-developed technology ecosystems and strong recognition of neurodiverse needs. The region benefits from early integration of digital solutions across healthcare, education, and employment sectors. Organizations actively use screening platforms to support inclusion, compliance, and early intervention initiatives. Availability of skilled professionals, favorable regulatory environments, and high adoption of remote assessment tools enhance market penetration. These combined factors position North America as the leading region in terms of overall market share.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, driven by improving awareness and expanding digital infrastructure. Educational institutions and healthcare organizations are turning to online screening solutions to meet growing demand efficiently. Supportive government programs, increased access to mobile technologies, and a rising emphasis on inclusive learning contribute to adoption. With a large and diverse population seeking accessible assessment options, the region is experiencing rapid uptake of digital neurodiversity platforms, making Asia Pacific the highest-growth market segment globally.

Key players in the market

Some of the key players in Neurodiversity Assessment & Screening Platforms Market include Lumosity, MoCA Cognition, HappyNeuron, Cognistat, BrainFx, Dystech, CogniFit, Cambridge Cognition, Creyos Health, CNS Vital Signs, Do-IT Profiler, GL Assessment, Qbtech, Gabify and Aignosis.

Key Developments:

In June 2025, Qbtech announces the formation of its Houston-based clinical research and strategic partnership teams, along with new staff appointments and promotions at the company's US headquarters. The employee expansions bolster the company's continued growth in the region, enhancing its capabilities and market presence as it continues to develop and enhance its software solutions.

In October 2016, CogniFit introduces CogniFit for Education, a new web-portal for teachers to assess, train, and monitor cognitive skills involved in the learning processes. The CogniFit for Education platform starts with students completing a scientifically validated and gamified cognitive assessment.

Components Covered:

  • Software Platforms
  • Services

Age Groups Covered:

  • Children (0-12 years)
  • Adolescents (13-17 years)
  • Adults (18+ years)

Deployment Modes Covered:

  • Cloud-Based
  • On-Premise

Applications Covered:

  • Dyslexia Screening
  • ADHD Screening
  • Autism Spectrum Disorder (ASD) Screening
  • Dyspraxia Screening

End Users Covered:

  • Educational Institutions
  • Healthcare Providers
  • Corporate Organizations
  • Research Institutes
  • Government Agencies

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Neurodiversity Assessment & Screening Platforms Market, By Component

  • 5.1 Introduction
  • 5.2 Software Platforms
  • 5.3 Services

6 Global Neurodiversity Assessment & Screening Platforms Market, By Age Group

  • 6.1 Introduction
  • 6.2 Children (0-12 years)
  • 6.3 Adolescents (13-17 years)
  • 6.4 Adults (18+ years)

7 Global Neurodiversity Assessment & Screening Platforms Market, By Deployment Mode

  • 7.1 Introduction
  • 7.2 Cloud-Based
  • 7.3 On-Premise

8 Global Neurodiversity Assessment & Screening Platforms Market, By Application

  • 8.1 Introduction
  • 8.2 Dyslexia Screening
  • 8.3 ADHD Screening
  • 8.4 Autism Spectrum Disorder (ASD) Screening
  • 8.5 Dyspraxia Screening

9 Global Neurodiversity Assessment & Screening Platforms Market, By End User

  • 9.1 Introduction
  • 9.2 Educational Institutions
  • 9.3 Healthcare Providers
  • 9.4 Corporate Organizations
  • 9.5 Research Institutes
  • 9.6 Government Agencies

10 Global Neurodiversity Assessment & Screening Platforms Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Lumosity
  • 12.2 MoCA Cognition
  • 12.3 HappyNeuron
  • 12.4 Cognistat
  • 12.5 BrainFx
  • 12.6 Dystech
  • 12.7 CogniFit
  • 12.8 Cambridge Cognition
  • 12.9 Creyos Health
  • 12.10 CNS Vital Signs
  • 12.11 Do-IT Profiler
  • 12.12 GL Assessment
  • 12.13 Qbtech
  • 12.14 Gabify
  • 12.15 Aignosis

List of Tables

  • Table 1 Global Neurodiversity Assessment & Screening Platforms Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Neurodiversity Assessment & Screening Platforms Market Outlook, By Component (2024-2032) ($MN)
  • Table 3 Global Neurodiversity Assessment & Screening Platforms Market Outlook, By Software Platforms (2024-2032) ($MN)
  • Table 4 Global Neurodiversity Assessment & Screening Platforms Market Outlook, By Services (2024-2032) ($MN)
  • Table 5 Global Neurodiversity Assessment & Screening Platforms Market Outlook, By Age Group (2024-2032) ($MN)
  • Table 6 Global Neurodiversity Assessment & Screening Platforms Market Outlook, By Children (0-12 years) (2024-2032) ($MN)
  • Table 7 Global Neurodiversity Assessment & Screening Platforms Market Outlook, By Adolescents (13-17 years) (2024-2032) ($MN)
  • Table 8 Global Neurodiversity Assessment & Screening Platforms Market Outlook, By Adults (18+ years) (2024-2032) ($MN)
  • Table 9 Global Neurodiversity Assessment & Screening Platforms Market Outlook, By Deployment Mode (2024-2032) ($MN)
  • Table 10 Global Neurodiversity Assessment & Screening Platforms Market Outlook, By Cloud-Based (2024-2032) ($MN)
  • Table 11 Global Neurodiversity Assessment & Screening Platforms Market Outlook, By On-Premise (2024-2032) ($MN)
  • Table 12 Global Neurodiversity Assessment & Screening Platforms Market Outlook, By Application (2024-2032) ($MN)
  • Table 13 Global Neurodiversity Assessment & Screening Platforms Market Outlook, By Dyslexia Screening (2024-2032) ($MN)
  • Table 14 Global Neurodiversity Assessment & Screening Platforms Market Outlook, By ADHD Screening (2024-2032) ($MN)
  • Table 15 Global Neurodiversity Assessment & Screening Platforms Market Outlook, By Autism Spectrum Disorder (ASD) Screening (2024-2032) ($MN)
  • Table 16 Global Neurodiversity Assessment & Screening Platforms Market Outlook, By Dyspraxia Screening (2024-2032) ($MN)
  • Table 17 Global Neurodiversity Assessment & Screening Platforms Market Outlook, By End User (2024-2032) ($MN)
  • Table 18 Global Neurodiversity Assessment & Screening Platforms Market Outlook, By Educational Institutions (2024-2032) ($MN)
  • Table 19 Global Neurodiversity Assessment & Screening Platforms Market Outlook, By Healthcare Providers (2024-2032) ($MN)
  • Table 20 Global Neurodiversity Assessment & Screening Platforms Market Outlook, By Corporate Organizations (2024-2032) ($MN)
  • Table 21 Global Neurodiversity Assessment & Screening Platforms Market Outlook, By Research Institutes (2024-2032) ($MN)
  • Table 22 Global Neurodiversity Assessment & Screening Platforms Market Outlook, By Government Agencies (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.